FDA inspection
Janssen Pharmaceuticals, Inc.: FDA inspection ending Nov 16, 1999
FDA inspection 4408 · No Action Indicated (NAI) · Raritan, NJ
Key facts
| Inspection ID | 4408 |
|---|---|
| Firm | Janssen Pharmaceuticals, Inc. |
| FEI number | 2211100 |
| Address | 1000 US Highway 202 |
| City | Raritan |
| State | NJ |
| ZIP | 08869-1425 |
| Fiscal year | 2000 |
| Inspection end date | Nov 16, 1999 |
| Classification | No Action Indicated (NAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data